A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MACE / major cardiac adverse events

[Related PubMed/MEDLINE]
Total Number of Papers: 49
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MACE  (>> Co-occurring Abbreviation)
Long Form:   major cardiac adverse events
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Clinical impact of diabetes mellitus on 2-year clinical outcomes following PCI with second-generation drug-eluting stents; Landmark analysis findings from patient registry: Pooled analysis of the Korean multicenter drug-eluting stent registry. DES, DM, IPTW, MI, PCI, TVR
2020 Clinical outcomes after implantation of polyurethane-covered cobalt-chromium stents. Insights from the Papyrus-Spain registry. CAA, CAP, CS, ST
2020 Comparison of revascularization strategies in patients with acute coronary syndrome and multivessel coronary disease: A systematic review and network meta-analysis. ACS, COI, CrI, MI, MV-index, MVD, OR
2020 Diabetes and calcification: The potential role of anti-diabetic drugs on vascular calcification regression. ADDs, CVD, DM, ILs, TNF-alpha, VC
2020 High-Density Lipoprotein Cholesterol Efflux Capacity as a Novel Prognostic Surrogate for Coronary Artery Disease. CAD, CEC, RV
2020 Identifying low-risk chest pain in the emergency department: Obstructive coronary artery disease and major adverse cardiac events. AUC, CAD, NRI
2020 Impact of Angiotensin II Receptor Blockers on Clinical Outcomes after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction Based on Data from the Korean National Health Insurance Database (2005-2014). ACEIs, AMI, ARBs, CI, HR, MI, PCI
2020 Left Ventricular Function and Myocardial Triglyceride Content on 3T Cardiac MR Predict Major Cardiovascular Adverse Events and Readmission in Patients Hospitalized with Acute Heart Failure. CMR, HF, LV, LVEDVI, MRS, TG
2020 [Prognosis of patients with vulnerable plaques indicated by coronary CT angiography]. CCTA, HR
10  2019 Long-Term Effects of Bosentan on Cardiovascular Events in Hispanic Patients with Intermittent Claudication: Four-Year Follow-up of the CLAU Trial : The CLAU Randomized Trial Long-Term Outcome. CLAU, HR, MAE, MALE, MI, PAD, TLR
11  2019 Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials. HF, LVEF, NRP, PCI, RCTs, RR, STEMI, TIMI, WMD, WMS
12  2019 Treatment with 48-mm everolimus-eluting stents : Procedural safety and 12-month patient outcome. EES
13  2019 [Outcome studies on SGLT-2 inhibitors]. CV, HHI, SGLT2
14  2018 Acute, total occlusion of the left main stem: coronary intervention options, outcomes, and recommendations. ACS, CPR, CS, PCI, SCD, uLMo
15  2018 Impact of persistent ST elevation on outcome in patients with Takotsubo syndrome. Results from the GErman Italian STress Cardiomyopathy (GEIST) registry. CI, GEIST, OR, PSTE, TTS
16  2018 Obesity paradox among elderly patients with coronary artery disease undergoing non-cardiac surgery. BMI, CI, OR
17  2018 Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome. CFR, FFR, IMR, IMR, IQR, NSTE-ACS, PCI
18  2018 The Significance of Equivocal Exercise Treadmill ECG for Intermediate Risk Chest Pain Assessment - Insight From Coronary CT Angiography Data. BMI, CAD, CCTA, ETT
19  2017 Best Clinical Practice: Current Controversies in the Evaluation ofLow-Risk Chest Pain with Risk Stratification Aids. Part 2. ED, HEART
20  2017 Evaluation of coronary plaque characteristics with coronary computed tomography angiography in patients with non-obstructive coronary artery disease: a long-term follow-up study. CAD, CCTA, LAP, NRS, PB, PRI, SC, vl-ER
21  2017 Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis. MD, NSTEMI, RR, TO
22  2017 Role of residual acute stent malapposition in percutaneous coronary interventions. ASM, CLI-OPCI, IQ 0.1-0.4, OCT, ST
23  2016 Best Clinical Practice: Current Controversies in Evaluation of Low-Risk Chest Pain-Part 1. ACS, CCTA, ECG, ED, MI
24  2016 Establishment of a hybrid risk model to predict major cardiac adverse events in patients with non-ST-elevation acute coronary syndromes. GRACE, LG, NSTE-ACS, ROCs
25  2016 Gender differences in the association between serum uric acid and prognosis in patients with acute coronary syndrome. ACS, HR, ICAS, UA
26  2016 High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis. CMR, LGE
27  2015 Improved long-term survival for diabetic patients with surgical versus interventional revascularization. CABG, CI, CR, OR, PCI
28  2015 Role of coronary artery calcium score for risk stratification in patients with non significant perfusion defects by myocardial perfusion single photon emission computed tomography. CAC, CAD, MPS
29  2015 The association between elevated admission systolic blood pressure in patients with acute coronary syndrome and favorable early and late outcomes. ACS, ACSIS, HRs, SBP
30  2015 Thirty-day readmission rates after PCI in a metropolitan center in Europe: incidence and impact on prognosis. ACS, OR, PCI
31  2014 Association of beta-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study. HF, HR
32  2014 Change in growth differentiation factor 15, but not C-reactive protein, independently predicts major cardiac events in patients with non-ST elevation acute coronary syndrome. GDF15, hs-CRP, NSTE-ACS
33  2014 Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry. AA, DAPT, HPR, MEA, PCI, ST, STEMI, TIMI
34  2014 Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. MO
35  2014 Very late outcomes of drug-eluting stents coated with biodegradable polymers: insights from the 5-year follow-up of the randomized PAINT trial. BMS, BP, DES, MI, PES, SES, ST, TVR
36  2013 One-year clinical outcome of patients treated with or without abciximab in rescue coronary angioplasty. AMI, CI, HR, OR
37  2013 Treatment of sirolimus-eluting stent restenosis: additional stent, balloon angioplasty, and coronary artery bypass graft. CABG group, PCI, SES
38  2013 Using extracorporeal membrane oxygenation to rescue acute myocardial infarction with cardiopulmonary collapse: the impact of early coronary revascularization. AMI, CABG, ECMO, PCI
39  2013 [The effects of cytochrome P450 2C19 genetic polymorphism on clopidogrel resistance and recent prognosis of patients with acute coronary syndrome]. ACS, CR, PAR, PCR-RFLP
40  2012 Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis. PON1
41  2011 Are patients with angiographically near-normal coronary arteries who present as acute myocardial infarction actually safe? AMI, KAMIR
42  2011 Comparison of one-year outcome of patients aged <75 years versus ≥75 years undergoing "rescue" percutaneous coronary intervention. PCI
43  2011 Prosthesis-patient mismatch after mitral valve replacement stratified by referred and measured effective valve area. EOAI, m-EOA, MPG, MVA, MVR, PPM, r-EOA
44  2011 The pharmacokinetics of Biolimus A9 after elution from the BioMatrix II stent in patients with coronary artery disease: the Stealth PK Study. ---
45  2010 Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry. PCIs
46  2009 Impact of different clinical pathways on outcomes of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the RAPID-AMI study. CCU, STEMI
47  2005 Prospective randomized comparison of early and late results of a carbonized stent versus a high-grade stainless steel stent of identical design: the PREVENT Trial [corrected]. ---
48  2004 Angioplasty and stents in coronary artery disease: a systematic review and meta-analysis. AMI, BR, CAD, ORs, PTCA, RCTs
49  2004 Primary direct stenting versus endoscopic atraumatic coronary artery bypass surgery in patients with proximal stenosis of the left anterior descending coronary artery--a prospective, randomised study. EACAB, LAD, PDS